NewAmsterdam Pharma pany N.V.(NAMS) - 2025 Q2 - Quarterly Results
NewAmsterdam Pharma pany N.V.(US:NAMS)2025-08-06 11:00– Late Breaking BROADWAY and TANDEM data presented at EAS 2025 and simultaneously published in The New England Journal of Medicine (BROADWAY) and The Lancet (TANDEM) – – BROADWAY Alzheimer's disease analysis presented at AAIC 2025 showed obicetrapib significantly reduced plasma p- tau217 levels versus placebo in both the full analysis set and in ApoE4 carriers, over 12 months, with favorable trends observed in additional Alzheimer's biomarkers – NewAmsterdam Pharma Provides Corporate Update and Reports Seco ...